Latest news with #YolandaHu
Business Insider
01-06-2025
- Business
- Business Insider
Citi Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
In a report released yesterday, from Citi maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report), with a price target of HK$9.20. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter In addition to Citi, CSPC Pharmaceutical Group also received a Buy from Morgan Stanley's Yolanda Hu in a report issued yesterday. However, on the same day, Macquarie maintained a Hold rating on CSPC Pharmaceutical Group (Other OTC: CHJTF). The company has a one-year high of $0.96 and a one-year low of $0.44. Currently, CSPC Pharmaceutical Group has an average volume of 35.52K.
Business Insider
31-05-2025
- Business
- Business Insider
Morgan Stanley Remains a Buy on CSPC Pharmaceutical Group (CHJTF)
Morgan Stanley analyst Yolanda Hu maintained a Buy rating on CSPC Pharmaceutical Group (CHJTF – Research Report) yesterday and set a price target of HK$6.80. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Hu is ranked #9102 out of 9552 analysts. In addition to Morgan Stanley, CSPC Pharmaceutical Group also received a Buy from Nomura's Jialin Zhang in a report issued on May 29. However, yesterday, Macquarie maintained a Hold rating on CSPC Pharmaceutical Group (Other OTC: CHJTF).
